FDA May 23 Recall Check: Salmonella Drink Mixes And Hidden Sildenafil Chocolate

BadPD source-check, May 24, 2026: FDA’s May 23 recall page added two consumer-safety items that deserve more than a scroll-past. SKS Copack of Cerritos, California, recalled specialty beverage products sold under Angel Specialty Products, Royal Gold, Boba Time, Fanale, and Denda because of possible Salmonella contamination. JXK Enterprises separately recalled Boner Bears Chocolate because FDA laboratory analysis confirmed undeclared sildenafil, the active ingredient in Viagra.

The two recalls are different, but the accountability frame is the same: consumers should not need to become supply-chain detectives to figure out whether a cafe powder, blended-drink mix, or online sexual-enhancement chocolate is carrying a hidden hazard. FDA posted the notices as company announcements, and FDA says it does not endorse the companies or products. BadPD is treating FDA as the control record for product identifiers and consumer instructions, then checking the wider paper trail for how the hazards got there and what is still missing.

Quick Action

For SKS Copack beverages: check Angel Specialty Products, Royal Gold, Boba Time, Fanale, and Denda products against the FDA table. The recall involves specific item codes, lot codes, and best-by dates. FDA says the affected products moved through cafes, restaurants, and direct delivery in many states. If a product matches the recall, return it to the place of purchase for a refund and do not use it in drinks, soft serve, smoothies, milk tea, coffee drinks, or food prep.

For Boner Bears Chocolate: check for Boner Bears Sex Chocolate, lot BB21125, expiration 02/2026, 22g individually wrapped black-labeled bars marked “Fast Acting Max Strength” and “3 Doses Per Bar.” FDA’s notice says the product was distributed nationwide through online sales. If it matches, stop using it immediately and contact the company for return or refund instructions.

What FDA Confirmed For SKS Copack

FDA’s SKS Copack recall notice lists a company announcement date of May 22, 2026 and an FDA publish date of May 23, 2026. The product type is food and beverages. The recall reason is Salmonella contamination. The brand names listed are Angel Specialty Products, Royal Gold, Boba Time, Fanale, and Denda. The product description is specialty beverages.

The public notice says SKS Copack is recalling various specialty beverage products because they have the potential to be contaminated with Salmonella. FDA’s posted company text gives the basic health risk: Salmonella can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy people can experience fever, diarrhea, nausea, vomiting, and abdominal pain; in rare cases the organism can get into the bloodstream and cause more severe illnesses.

The distribution footprint is broad. FDA says the recalled products were distributed in CA, UT, ID, NY, NJ, AZ, PA, NC, TX, OH, LA, GA, FL, IL, OK, MA, WA, OR, WI, NV, VA, CT, TN, KY, and MN through cafes, restaurants, and direct delivery. That matters because a consumer may never see a retail bag. They may encounter an affected ingredient after it has already been turned into a cafe drink, smoothie, blended creme, milk tea, coconut drink, soft-serve base, or flavored powder mix.

FDA’s affected-product table includes the following item names and identifiers: Angel Specialty Products Matcha Green Tea 4/3# with lot codes 20260224 and 20260424; Angel Specialty Products Taro 4/3# with lot 20260224; Angel Specialty Products Caramel Latte 4/3# with lot 20260414; Angel Specialty Products Coconut 4/3# with lot 20260415; Angel Specialty Products Horchata 4/3# with lots 20260414 and 20260424; Angel Specialty Products Vanilla Smoothie Base 4/3# with lot 20260413; Angel Specialty Products White Chocolate 4/3# with lot 20260327; Angel Specialty Products Milk Tea 15/3# with lot 20260224; Royal Gold Dutch Mocha Capp 6/2# with lot 20260303; Angel Specialty Products Strawberry Soft Srv 10/2# with lot 20260414; Boba Time Italian Yogurt Powder 5/3.5# with lot 20260216; Boba Time Coconut Powder 5/3.5# with lot 20260428; Boba Time Pistachio Powder 5/3.5# with lot 20260219; Fanale Ube-Taro 10/2# with lot 20260223; Denda Milk Ice Cream Mix 12/1KG with lot 20260403; and Royal Gold French Vanilla Capp 6/2# with lot 20260416.

FDA says no illnesses have been reported to date in the SKS Copack recall. That is important, but it should not end the record. The recall is preventive because routine testing at an upstream supplier reportedly found a positive Salmonella result, and downstream products used that ingredient. The absence of reported illness does not mean the affected ingredient pathway is irrelevant. It means the public should move fast enough that illnesses do not have to become the proof.

The Powdered-Milk Supply Chain

The SKS notice says the recall was initiated after SKS Copack received notification from its supplier about a voluntary recall by California Dairies, Inc. for a certain lot of low-heat nonfat dry milk powder due to possible Salmonella contamination. According to the FDA-posted company text, California Dairies said the recall followed positive Salmonella results associated with routine product testing. FDA says the remaining recalled ingredient lot was quarantined, SKS Copack ceased distribution of the recalled products, and the company is cooperating with FDA as the investigation continues.

Cheese Reporter published a May 15 account of the California Dairies recall that gives the downstream context. It reported that California Dairies recalled bulk powdered milk and buttermilk powder distributed to multiple wholesale distributors and manufacturers, and that FDA said it was working with downstream consignees to determine whether additional downstream customer recalls were necessary. Cheese Reporter also reported that California Dairies’ voluntary Class I recall involved more than 2.6 million pounds of low-heat nonfat dry milk and nearly 20,000 pounds of buttermilk powder.

That is the bigger story behind the SKS consumer notice. A pathogen concern in bulk dairy powder can turn into cafe powders, drink bases, seasoning mixes, ice cream bases, and other downstream products. A recall then becomes less about one brand and more about tracing the ingredient through processors, repackagers, cafes, restaurants, direct-delivery accounts, and retail-form examples. Consumers only see the last label. FDA and the companies have to show the path.

What FDA Confirmed For Boner Bears Chocolate

FDA’s Boner Bears notice lists a company announcement date of May 21, 2026 and an FDA publish date of May 23, 2026. JXK Enterprises is recalling Boner Bears Chocolate, lot BB21125, after FDA laboratory analysis confirmed sildenafil in the product even though it was not declared on the label. FDA says sildenafil is approved for use only under the supervision of a licensed healthcare professional for treatment of erectile dysfunction.

The hazard is not embarrassment. The hazard is undeclared prescription-drug exposure. FDA’s posted company notice says products containing undeclared sildenafil may pose serious health risks because sildenafil can interact with nitrates found in certain prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. The notice says people with diabetes, high blood pressure, high cholesterol, or heart disease are at increased risk because of potential interactions.

The recalled product is marketed as a sexual-enhancement product and was distributed nationwide through online sales. FDA says no other lots or products are included in the JXK recall and that JXK Enterprises has not received adverse-event reports related to the recall to date. Consumers with questions are directed to JXK Enterprises at (954) 281-2459 or compliance@elyxr.com, Monday through Friday, 9 a.m. to 6 p.m. Pacific.

This Was Not The First Boner Bears Warning

The May 23 recall does not appear out of nowhere. FDA had already warned consumers on February 13, 2026 not to purchase or use Boner Bears Chocolate Bars sold on elyxr.com or Boner Bears Chocolate Syrup sold on lockoutsupplements.com after FDA laboratory analysis found sildenafil not listed on the label. FDA then posted a February 25 recall by Lockout Supplements for Boner Bears Chocolate Syrup because of undeclared sildenafil. On March 30, FDA warned that Boner Bears Honey may be harmful because laboratory analysis found sildenafil and tadalafil not listed on the label.

That pattern is the accountability angle. When the same brand lane keeps returning through different product forms — chocolate bars, syrup, honey — consumers need more than one isolated recall notice. They need the plain warning: do not assume a sexual-enhancement candy, honey, gummy, syrup, or novelty supplement is safe because it is sold as food or a casual online product. Hidden prescription-drug ingredients can create real cardiovascular risk, especially when a person is already taking nitrates or has underlying heart-risk factors.

FDA’s health-fraud pages are relevant here because they show this is a broader enforcement category. The agency repeatedly warns that products promoted for sexual enhancement can contain hidden drug ingredients. A product can look like candy and still function like an unprescribed drug exposure. That is why the public instruction should be direct, not coy: check the lot, stop using it if recalled, report adverse events, and do not mix novelty sexual-enhancement products with prescription medication without medical supervision.

Confirmed, Alleged, Pending

Confirmed for SKS: FDA published the SKS Copack recall on May 23, 2026. The company announcement date is May 22. The affected brands are Angel Specialty Products, Royal Gold, Boba Time, Fanale, and Denda. FDA says the reason is Salmonella contamination and lists specific item codes, lots, and best-by dates. FDA says distribution included 25 states through cafes, restaurants, and direct delivery. FDA says no illnesses have been reported to date.

Confirmed for Boner Bears: FDA published the JXK Enterprises recall on May 23, 2026. The company announcement date is May 21. The affected product is Boner Bears Sex Chocolate, lot BB21125, expiration 02/2026, 22g black-labeled bar. FDA says laboratory analysis confirmed undeclared sildenafil. FDA says no adverse events have been reported to the company to date. FDA’s earlier February and March notices document prior Boner Bears hidden-drug warnings in related product forms.

Alleged or not yet complete: BadPD is not claiming any illness has been linked to SKS Copack products. BadPD is not claiming an adverse event has been linked to the JXK Boner Bears recall. The hazard records are recalls and FDA testing notices, not outbreak findings. Consumers should still act because recalls are designed to remove risk before the illness count becomes the evidence.

Pending: the SKS lane still needs retailer, cafe, and direct-customer notification receipts; full downstream consignee lists; whether any recalled powder was used in prepared drinks after the supplier notice; whether any state health departments receive illness reports; and whether more downstream recalls from the California Dairies ingredient issue appear. The Boner Bears lane needs clarity on current online sales status, marketplace removals, whether FDA or the company tested any other lots, and whether earlier health-fraud warnings produced enforcement beyond recall notices.

Consumer Accountability Angle

This is where BadPD should be practical. Salmonella recall coverage should not only say “possible contamination.” It should ask whether cafes and restaurants know they may be holding affected powders and whether customers can find out if a drink they bought used them. A food-service ingredient recall is harder for the public than a grocery item recall because the consumer often does not see the bag, lot code, or best-by date. That puts more responsibility on SKS, distributors, cafes, and direct-delivery accounts to notify quickly and visibly.

For cafes and restaurants, the minimum standard should be visible inventory control. Pull affected products from prep areas, mark them so they cannot be accidentally used, keep a record of the item code and lot, identify whether any prepared drinks were made after the supplier notice, and document which customers or wholesale accounts received affected product. If a cafe cannot tell which lot was used in a drink base, that is not the customer’s fault. It is a traceability failure that belongs upstream in purchasing, storage, and preparation records.

For distributors, the standard should be named account notification, not passive recall awareness. If products went to cafes, restaurants, or direct-delivery accounts in 25 states, the recall should leave a receipt trail: date notified, contact method, product pulled, product returned or destroyed, and whether any downstream account asked for public-facing customer language. FDA’s public notice tells consumers to return products to the place of purchase for a refund. That instruction only works when the place of purchase knows what is recalled and can answer basic questions without improvising.

The hidden-sildenafil recall needs a different kind of plain language. Sexual-enhancement branding can make serious drug exposure look like a joke product. It is not a joke for someone taking nitroglycerin or another nitrate medication. It is not a joke for someone with heart disease, high blood pressure, diabetes, or high cholesterol. If an online product contains a prescription drug that is not declared on the label, the consumer has been denied informed consent.

The shared standard is simple: labels should tell people what they are consuming, ingredient suppliers should trigger downstream recalls fast, food-service accounts should remove affected product before it becomes a prepared drink, and online sellers should not wait for repeated FDA lab findings before cleaning up a hidden-drug brand lane. “No illnesses reported” and “no adverse events reported” are good news, not a reason to slow down.

What To Watch Next

Watch FDA’s recall index for more downstream California Dairies-linked products. Watch state health departments in the listed SKS distribution states for Salmonella illness notices. Watch cafe chains, distributors, and Angel Specialty Products channels for customer notices that name where product went. For Boner Bears, watch FDA’s health-fraud notifications, marketplace takedown activity, and whether additional lots or related product forms appear.

BadPD will keep this in the consumer watch lane. The SKS item deserves direct cafe and distributor follow-through because prepared-drink customers may not know they were exposed to an affected ingredient. The Boner Bears item deserves hidden-drug follow-through because FDA’s 2026 record already shows repeated Boner Bears-linked warnings across chocolate, syrup, and honey. The immediate public move is straightforward: check the FDA notices, stop using matching products, return or discard them under the recall instructions, and report illnesses or adverse reactions through the proper health channels.

Source Trail

• FDA recall index: May 23 listings for SKS Copack and Boner Bears (Content current as of May 23, 2026) – Control page showing both May 23 recalls, product categories, reason descriptions, and company names.
• FDA: SKS Copack recalls specialty beverages because of Salmonella risk (Company announcement May 22, 2026; FDA publish date May 23, 2026) – Primary recall notice with brands, affected item codes, lots, best-by dates, distribution states, supplier link, no-illness statement, and company contact.
• Food Safety News: Angel Specialty drinks recalled because of Salmonella risk (May 23, 2026) – Independent food-safety outlet repeating the SKS recall and consumer-risk frame.
• Cheese Reporter: CDI recalls bulk powdered milk and buttermilk powder (May 15, 2026) – Supply-chain receipt connecting California Dairies Inc. powdered-milk recall to downstream manufacturers and noting FDA said more downstream recalls could be necessary.
• FDA: JXK Enterprises recalls Boner Bears Chocolate due to undeclared sildenafil (Company announcement May 21, 2026; FDA publish date May 23, 2026) – Primary recall notice identifying lot BB21125, expiration 02/2026, online nationwide distribution, and risk from undeclared sildenafil.
• FDA health fraud notice: Boner Bears Chocolate may be harmful due to hidden drug ingredient (February 13, 2026) – Earlier FDA warning that laboratory analysis found sildenafil in Boner Bears Chocolate Bars and Chocolate Syrup sold through named websites.
• FDA: Lockout Supplements recalls Boner Bears Chocolate Syrup (February 25, 2026) – Prior recall showing the same brand lane had already hit FDA for undeclared sildenafil in chocolate syrup.
• FDA: Boner Bears Honey may be harmful due to hidden drug ingredients (March 30, 2026) – Pattern receipt: FDA warned consumers not to purchase or use Boner Bears Honey after laboratory analysis found undeclared sildenafil and tadalafil.